The nation of Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (£272m) spanning five years because of Washington's insistence on confidential data.
The decision came to light after a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesperson later explained that the United States was demanding access to biological samples for scientific study and commercial gain while was not willing to guarantee the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued talks to reach a agreement agreeable to all parties so the nation's critical HIV treatment initiative can be sustained.
Wider Implications
This development follows a similar case in Kenya, where a court halted a similar deal with the US after legal challenges were filed about the security of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral deals to boost openness and responsibility.
According to statements, 16 African countries have so far signed these new agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.
"Effectively, our country would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our people should a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems previously set up via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This system is intended to guarantee that when a country contributes its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," he added.
"We welcome continued dialogue with our American counterparts on how future co-operation might be designed in a way that respects the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but suggested that negotiations must proceed given that much of the nation's Aids initiatives depended on foreign aid.
"In cases where technical issues arise, including those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.
The halted deal highlights the ongoing challenges between receiving vital international aid and protecting local interests in an increasingly interconnected world.